Article
Perampanel reduces seizure frequency in patients with developmental and epileptic encephalopathy for a long term
2024-10-22
Abstract excerpt
<title>Abstract</title> <p>Seizures in patients with developmental and epileptic encephalopathies (DEEs) are often highly resistant to various antiseizure medications. Perampanel (PER) is a novel antiseizure medication that non-competitively inhibits the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor and is expected to reduce seizure frequency not only for focal seizures and generalized tonic-cloni...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 752a5063-d9a9-59ca-adcc-c14f7e3756c8
- DOI
- 10.21203/rs.3.rs-5286706/v1